-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Whitehawk Therapeutics, Inc. quarterly/annual Depreciation history and change rate from Q1 2016 to Q3 2025.
- Whitehawk Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $5.6K, a 88% decline year-over-year.
- Whitehawk Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $132K, a 40.5% decline year-over-year.
- Whitehawk Therapeutics, Inc. annual Depreciation for 2024 was $200K, unchanged from 2023.
- Whitehawk Therapeutics, Inc. annual Depreciation for 2023 was $200K, a 100% increase from 2022.
- Whitehawk Therapeutics, Inc. annual Depreciation for 2022 was $100K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)